Company profile
HCA Healthcare, Inc.
NYSE:HCAHospital/Nursing Management
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06937385 | phase3 | not_yet_recruiting | 2025-05-01 | 2026-05-01 | HCA Florida North Florida Hospital | 0.5% Bupivacaine Lower Cervical Intramuscular Injection vs IV Medications for Headache Treatment |
| NCT00973999 | phase2 | withdrawn | 2009-09-01 | 2011-09-01 | HCA International Limited | Botulinum Toxin and Saliva Management in Tracheotomised Patients |
| NCT04750395 | phase2 | unknown | 2021-09-01 | 2024-05-01 | HCA Hospice Care | Comparing Haloperidol and Olanzapine in Treating Terminal Delirium |
FDA applications (0)
No records yet.